Genotype, molecular phenotype, and cognitive phenotype: correlations in fragile X syndrome
- PMID: 10208163
Genotype, molecular phenotype, and cognitive phenotype: correlations in fragile X syndrome
Abstract
The study of the neurobehavioral consequences of mutations of FMR1, the gene responsible for fragile X syndrome (FraX), has been based largely on correlations between mutation patterns and cognitive profile. Following the characterization of FMRP, the FMR1 gene product, preliminary correlations between FMRP levels, and neurologic phenotype have been established. However, most of these investigations have focused on individuals at both ends of the genetic and cognitive spectra of FraX, subjects with normal or premutation (PM) alleles or males with the FMR1 full mutation (FM). The present study is designed to characterize FMRP expression and to correlate it with IQ, in a sample representing a wide spectrum of FMR1 mutations. For this purpose we developed a highly sensitive immunoblotting assay using peripheral leukocytes. Three distinct patterns of FMRP immunoreactivity (-ir) emerged. Individuals with normal (n = 28) and PM (n = 8) alleles as well as most females with the FM (n = 14) showed the highest levels with multiple approximately 70-80 kDa FMRP-ir bands. Males with the FM (n = 10) demonstrated only a 70 kDa FMRP-ir band, and had significantly lower levels when compared with any previous groups. Males with mosaicism and three of 14 females with FM displayed a doublet with equal amounts of the highest and lowest molecular weight FMRP-ir bands. Multiple regression models that adjust for the effect of parental IQ indicated that both activation ratio and FMRP-ir are significantly correlated to subject IQ. We conclude that FMRP-ir offers promise as an indicator of the impact of FMR1 mutations upon neurologic function. Furthermore, our unexpected finding of FMRP-ir in all males with FM suggests that most of them are not transcriptionally silent.
Similar articles
-
FMRP expression as a potential prognostic indicator in fragile X syndrome.Am J Med Genet. 1999 May 28;84(3):250-61. Am J Med Genet. 1999. PMID: 10331602
-
Molecular phenotype of Fragile X syndrome: FMRP, FXRPs, and protein targets.Microsc Res Tech. 2002 May 1;57(3):135-44. doi: 10.1002/jemt.10066. Microsc Res Tech. 2002. PMID: 12112448 Review.
-
Exceptional good cognitive and phenotypic profile in a male carrying a mosaic mutation in the FMR1 gene.Clin Genet. 2007 Aug;72(2):138-44. doi: 10.1111/j.1399-0004.2007.00829.x. Clin Genet. 2007. PMID: 17661818
-
The emerging fragile X premutation phenotype: evidence from the domain of social cognition.Brain Cogn. 2005 Feb;57(1):53-60. doi: 10.1016/j.bandc.2004.08.020. Brain Cogn. 2005. PMID: 15629215 Clinical Trial.
-
Phenotypic variation and FMRP levels in fragile X.Ment Retard Dev Disabil Res Rev. 2004;10(1):31-41. doi: 10.1002/mrdd.20006. Ment Retard Dev Disabil Res Rev. 2004. PMID: 14994286 Review.
Cited by
-
Association between IQ and FMR1 protein (FMRP) across the spectrum of CGG repeat expansions.PLoS One. 2019 Dec 31;14(12):e0226811. doi: 10.1371/journal.pone.0226811. eCollection 2019. PLoS One. 2019. PMID: 31891607 Free PMC article.
-
Fragile X syndrome: a review of clinical and molecular diagnoses.Ital J Pediatr. 2017 Apr 19;43(1):39. doi: 10.1186/s13052-017-0355-y. Ital J Pediatr. 2017. PMID: 28420439 Free PMC article. Review.
-
FMR1 mRNA from full mutation alleles is associated with ABC-CFX scores in males with fragile X syndrome.Sci Rep. 2020 Jul 16;10(1):11701. doi: 10.1038/s41598-020-68465-6. Sci Rep. 2020. PMID: 32678152 Free PMC article.
-
Epigenetics in nucleotide repeat expansion disorders.Semin Neurol. 2011 Nov;31(5):470-83. doi: 10.1055/s-0031-1299786. Epub 2012 Jan 21. Semin Neurol. 2011. PMID: 22266885 Free PMC article. Review.
-
Methylation of novel markers of fragile X alleles is inversely correlated with FMRP expression and FMR1 activation ratio.Hum Mol Genet. 2010 Apr 15;19(8):1618-32. doi: 10.1093/hmg/ddq037. Epub 2010 Jan 29. Hum Mol Genet. 2010. PMID: 20118148 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical